Skip to Main Content

Paper Details

Nonclassical antigen-processing pathways are required for MHC class II-restricted direct tumor recognition by NY-ESO-1-specific CD4(+) T cells.
Cancer Immunol Res
35
2014
-specific CD4(+) T cells, CD4, CD4(+), CD4(+) T cells, DP04, DP04(+) target cells, HLA-DPB1*04, MHC class I, MHC class II, MHC-II, MHC-II antigen, NY, NY-ESO-1, NY-ESO-1 protein, NY-ESO-1-specific CD4(+) T cells, NY-ESO-1157-170, Tumor antigen, Tumor antigen-specific CD4(+) T cells, cancer, cancer cells, endosomal/lysosomal proteases, intracellular NY-ESO-1, non-tumor-recognizing CD4(+) T cells, ovarian cancer, patients, primaquine, target cells, tumor, tumor-recognizing CD4(+) T cells

Datasets

Release 1.2